Pomalidomide Capsule
Product Images NDC 72205-179

9 FDA label images from Novadoz Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 72205-179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pomalidomide-capsules-1 (Pomalidomide Capsules 1)

Pomalidomide-capsules-1 (Pomalidomide Capsules 1)
Chemical structure of pomalidomide showing its molecular arrangement with labeled atoms including oxygen, nitrogen, and hydrogen.*
FDA Label Image

Figure-1 (Pomalidomide Capsules 2)

Figure-1 (Pomalidomide Capsules 2)
A Kaplan-Meier survival curve graph depicting progression-free survival over months for two treatment groups: HD-DEX (solid blue line) and POM+LD-DEX (dashed red line). The y-axis shows the proportion of subjects, and the x-axis indicates months of survival. Number of subjects at risk is listed below the graph for both groups.*
FDA Label Image

Figure-2 (Pomalidomide Capsules 3)

Figure-2 (Pomalidomide Capsules 3)
A Kaplan-Meier survival curve comparing overall survival in months between two treatment groups labeled HD-DEX and POM+LD-DEX. The y-axis shows the proportion of subjects surviving, and the x-axis shows time in months up to 24. A risk table below the graph indicates the number of subjects at risk over time for each group. Statistical details include a logrank p-value, hazard ratio with confidence interval, and median survival times.*
FDA Label Image

2mg-21 (Pomalidomide Capsules 4)

2mg-21 (Pomalidomide Capsules 4)
Label for pomalidomide capsules, 2 mg strength, containing 21 capsules. The label includes a warning about potential human birth defects and instructs pharmacists to dispense the Medication Guide to each patient. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. Storage instructions and a barcode are also present.*
FDA Label Image

2mg-100 (Pomalidomide Capsules 5)

2mg-100 (Pomalidomide Capsules 5)
Label for Pomalidomide Capsules 2 mg, an oral prescription drug. The label shows the strength as 2 mg and indicates a package size of 100 capsules. It is distributed by Novadoz Pharmaceuticals LLC. The label includes warnings about potential human birth defects and storage instructions, as well as manufacturing information from MSN Laboratories Private Limited, India.*
FDA Label Image

3mg-21 (Pomalidomide Capsules 6)

3mg-21 (Pomalidomide Capsules 6)
Pomalidomide Capsules 3 mg oral dosage label showing 21 capsules in the package. It includes a warning about potential human birth defects and instructs pharmacists to dispense an accompanying medication guide. The label lists the manufacturer as MSN Laboratories Private Limited, India, and the distributor as Novadoz Pharmaceuticals LLC, Piscataway, NJ. Storage instructions and dosage guidance references are also present.*
FDA Label Image

3mg-100 (Pomalidomide Capsules 7)

3mg-100 (Pomalidomide Capsules 7)
Label for Pomalidomide Capsules 3 mg by Novadoz Pharmaceuticals LLC. The label states it is Rx only, contains 100 capsules, and includes a warning about potential human birth defects. Storage instructions, manufacturing information for MSN Laboratories Private Limited, and distributor contact details are also visible.*
FDA Label Image

4mg-21 (Pomalidomide Capsules 8)

4mg-21 (Pomalidomide Capsules 8)
Label for Pomalidomide Capsules 4 mg, an oral prescription drug by Novadoz Pharmaceuticals LLC. The label indicates a package quantity of 21 capsules, with warnings about potential human birth defects and storage instructions. Manufactured by MSN Laboratories in India and distributed by Novadoz Pharmaceuticals in New Jersey, USA.*
FDA Label Image

4mg-100 (Pomalidomide Capsules 9)

4mg-100 (Pomalidomide Capsules 9)
Label for Pomalidomide Capsules 4 mg by Novadoz Pharmaceuticals LLC. The label indicates the product is prescription only, with a warning about potential for human birth defects. The label provides storage instructions and manufacturer information, stating the capsules come in a 100 count package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.